Antiinflammatory effects of mercaptoethylguanidine, a combined inhibitor of nitric oxide synthase and peroxynitrite scavenger, in carrageenan-induced models of inflammation

Free Radical Biology and Medicine

Volumn 24, Issue 3, 1998, Pages 450-459

  Cuzzocrea, Salvatore ^a   Zingarelli, Basilia ^a   Hake, Paul ^a   Salzman, Andrew L ^a   Szabo, Csaba ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Carrageenin; Free radicals; Inflammation; Nitric oxide; NO synthase; Peroxynitrite; Prostaglandins; Shock; Superoxide

Indexed keywords

CARRAGEENAN; FREE RADICAL; GUANIDINE DERIVATIVE; NITRIC OXIDE SYNTHASE; PEROXYNITRITE; SUPEROXIDE;

ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ENZYME ACTIVITY; ENZYME INDUCTION; INFLAMMATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CARRAGEENAN; DISEASE MODELS, ANIMAL; EDEMA; ENZYME INHIBITORS; FREE RADICAL SCAVENGERS; GUANIDINES; INFLAMMATION; LUNG; MALE; NEUTROPHILS; NITRATES; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; OXIDANTS; PLEURISY; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA;

EID: 0031975261     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(97)00280-3     Document Type: Article

References (57)

1. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:1992;3051-3064.
2. Dinerman J. L., Lowenstein C. J., Snyder S. H. Molecular mechanisms of nitric oxide production. Potential relevance to cardiovascular disease. Circ. Res. 73:1993;217-222.
3. Szabó C. Alterations in the production of nitric oxide in various forms of circulatory shock. New Horiz. 3:1995;3-32.
4. Southan G. J., Szabó C. Selective pharmacological inhibition of distinct nitric oxide synthase isoforms. Biochem. Pharmacol. 51:1996;383-394.
5. Beckman J. S., Koppenol W. H. Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly. Am. J. Physiol. 271:1996;C1424-C1437.
6. Crow J. P., Beckman J. S. Reactions between nitric oxide, superoxide, and peroxynitrite: Footprints of peroxynitrite in vivo. Adv. Pharmacol. 34:1995;17-43.
7. Pryor W., Squadrito G. The chemistry of peroxynitrite: A product from the reaction of nitric oxide with superoxide. Am. J. Physiol. 268:1995;L699-L722.
8. Szabó C. The role of peroxynitrite in the pathophysiology of shock, inflammation and ischemia-reperfusion injury. Shock. 6:1996;79-88.
9. Rubbo H., Radi R., Trujillo M., Telleri R., Kalyanaraman B., Barnes S., Kirk M., Freeman B. A. Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives. J. Biol. Chem. 269:1994;26066-26075.
10. Szabó C., Salzman A. L., Ischiropoulos H. Peroxynitrite-mediated oxidation of dihydrorhodamine 123 occurs in early stages of endotoxic and hemorrhagic shock and ischemia-reperfusion injury. FEBS Lett. 372:1995;229-232.
11. Miles A. M., Bohle D. S., Glassbrenner P. A., Hansert B., Wink D. A., Grisham M. B. Modulation of superoxide-dependent oxidation and hydroxylation reactions by nitric oxide. J. Biol. Chem. 271:1996;40-47.
12. Pfeilschifter J., Eberhardt W., Hummel R., Kunz D., Muhl H., Nitsch D., Pluss C., Walker G. Therapeutic strategies for the inhibition of inducible nitric oxide synthase - Potential for a novel class of anti-inflammatory agents. Cell. Biol. Int. 20:1996;51-58.
13. Garvey E. P., Oplinger J. A., Tanoury G. J., Sherman P. A., Fowler M., Marshall S., Harmon M. F., Paith J. E., Furfine E. S. Potent and selective inhibition of human nitric oxide synthases. J. Biol. Chem. 269:1994;26669-26676.
14. Southan G. J., Szabó C., Thiemermann C. Isothioureas: Potent inhibitors of nitric oxide synthases with variable isoform selectivity. Br. J. Pharmacol. 114:1995;510-516.
15. Southan G. J., Szabó C., O'Connor M. P., Salzman A. L., Thiemermann C. Amidines are potent of nitric oxide synthases: Preferential inhibition of the inducible isoform. Eur. J. Pharmacol. 291:1995;311-318.
16. Southan G. J., Zingarelli B., O'Connor M., Salzman A. L., Szabó C. Spontaneous rearrangement of aminoalkylguanidines into mercaptoalkylguanidines - A novel class of nitric oxide synthase inhibitors with selectivity towards the inducible isoform. Br. J. Pharmacol. 117:1996;619-632.
17. Garvey E. P., Oplinger J. A., Furfine E. S., Kiff R. J., Laszlo F., Whittle B. J. R., Knowles R. G. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric oxide synthase in vitro and in vivo. J. Biol. Chem. 272:1997;4959-4963.
18. Stern M. K., Jensen M. P., Kramer K. Peroxynitrite decomposition catalysts. J. Am. Chem. Soc. 118:1996;8735-8736.
19. Szabó C., Day B. J., Salzman A. L. Evaluation of the relative contribution of nitric oxide and peroxynitrite to the suppression of mitochondrial respiration in immunostimulated macrophages, using a novel mesoporphyrin superoxide dismutase analog and peroxynitrite scavenger. FEBS Lett. 381:1996;82-86.
20. Salvemini D., Wang Z. Q., Wyatt D. M., Bourdon M. H., Marino P. T., Currie M. G. Nitric oxide: A key mediator in the early and late phase of carrageenan-induced rat paw inflammation. Br. J. Pharmacol. 118:1996;829-838.
21. Salvemini D., Wang Z. Q., Bourdon D. M., Stern M. K., Currie M. G., Manning P. T. Evidence of peroxynitrite involvement in the carrageenan-induced rat paw edema. Eur. J. Pharmacol. 303:1996;217-220.
22. Zingarelli B., Day B. J., Crapo J., Salzman A. L., Szabó C. The potential involvement of peroxynitrite in the pathogenesis of endotoxic shock. Br. J. Pharmacol. 120:1997;259-267.
23. Zingarelli B., Southan G. J., Gilad E., Salzman A. L., Szabó C. Mercaptoalkylguanidines are direct inhibitors of cyclooxygenase activity. Br. J. Pharmacol. 120:1997;357-366.
24. Kozak A., Arient M. Metabolism and radioprotective effect of AET and MEG in organism. Strahlentherapie. 146:1973;367-373.
25. Shapira R., Doherty D. G., Burnett W. T. Chemical protection against ionizing radiation. III. Mercaptoalkylguanidines and related isothiouronium compounds with protective activity. Radiat. Res. 7:1957;22-34.
26. Szabó C., Ferrer-Sueta G., Zingarelli B., Southan G. J., Salzman A. L., Radi R. Mercaptoethylguanidine and related guanidine nitric oxide synthase inhibitors react with peroxynitrite and protect against peroxynitrite-induced oxidative damage. J. Biol. Chem. 272:1997;9030-9036.
27. Tracey W. R., Nakane M., Kuk J., Budzik G., Klinghofer V., Harris R., Carter G. The nitric oxide synthase inhibitor, L-NG-monomethylarginine, reduces carrageenan-induced pleurisy in the rat. J. Pharmacol. Exp. Ther. 273:1995;1295-1299.
28. Wei X. Q., Charles I. G., Smith A., Ure J., Feng G. J., Huang F. P., Xu D., Muller W., Moncada S., Liew F. Y. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature. 375:1995;408-411.
29. Cuzzocrea S., Zingarelli B., Calapai G., Nava F., Caputi A. P. Zymosan-activated plasma induces paw oedema by nitric oxide and prostaglandin production. Life Sci. 60:1997;215-220.
30. Di Rosa M., Willoughby D. A. Screens for anti-inflammatory drugs. J. Pharm. Pharmacol. 23:1971;297-300.
31. Cuzzocrea S., Zingarelli B., Costantino G., Szabó A., Salzman A. L., Caputi A. P., Szabó C. Beneficial effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase in a rat model of splanchnic artery occlusion and reperfusion. Br. J. Pharmacol. 121:1997;1065-1074.
32. Mullane K. M., Kraemer R., Smith B. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J. Pharmacol. Methods. 14:1985;157-167.
33. Remacle J., Raes M., Toussaint O., Renard P., Rao G. Low levels of reactive oxygen species as modulators of cell function. Mutat. Res. 316:1995;103-122.
34. Sun Y., Oberley L. W. Redox regulation of transcriptional activators. Free Radic. Biol. Med. 21:1996;335-348.
35. Salzman A. L., Denenberg A. G., Ueta I., O'Connor M., Linn S., Szabó C. Characterization of the induction and activity of the human nitric oxide synthase in a transformed intestinal epithelial cell line. Am. J. Physiol. 270:1996;G565-G573.
36. Ruetten H., Thiemermann C. Prevention of the expression of inducible nitric oxide synthase by aminoguanidine or aminoethyl-isothiourea in macrophages and in the rat. Biochem. Biophys. Res. Commun. 225:1996;525-530.
37. Connor J., Manning P., Settle S., Moore W., Jerome G., Webber R., Tjoeng F., Currie M. Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthase. Eur. J. Pharmacol. 273:1995;15-24.
38. Anderson G. D., Hauser S. D., McGarity K. L., Bremer M. E., Isakson P. C., Gregory S. A. Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. J. Clin. Invest. 97:1996;2672-2679.
39. Salvemini D., Masferrer J. L. Interactions of nitric oxide with cyclooxygenase: In vitro, ex vivo, and in vivo studies. Methods Enzymol. 269:1996;12-25.
40. Manfield L., Jang D., Murrell G. A. C. Nitric oxide enhances cyclooxygenase activity in articular cartilage. Inflamm. Res. 45:1996;254-258.
41. Xia Y., Dawson V. L., Dawson T. M., Snyder S. H., Zweier J. L. Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc. Natl. Acad. Sci. USA. 93:1996;6770-6774.
42. Wojtecka-Lukasik E., Maslinski S. Polymorphonuclear leukocyte collagenase in carrageenin-induced inflammation: Effect of nonsteroidal antiinflammatory drugs. Int. J. Tissue React. 8:1986;321-325.
43. Sopata I., Wojtecka-Lukasik E., Wize J., Maslinski S. Neutrophil enzyme activities in carrageenan-induced inflammation in rats. Agents Actions. 28:1989;89-92.
44. Oh-ishi S., Hayashi I., Hayashi M., Yamaki K., Utsunomiya I. Pharmacological demonstration of inflammatory mediators using experimental inflammatory models: Rat pleurisy induced by carrageenin and phorbol myristate acetate. Dermatologica. 179:(Suppl 1):1989;68-71.
45. Peskar B. M., Trautmann M., Nowak P., Peskar P. A. Release of 15-hydroxy-5,8,11,13-eicosatetraenoic acid and cysteinyl-leukotrienes in carrageenin-induced inflammation: Effect of nonsteroidal anti-inflammatory drugs. Agents Actions. 33:1991;240-246.
46. Dawson J., Sedgwick A. D., Edwards J. C., Lees P. A comparative study of the cellular, exudative and histological responses to carrageenan, dextran and zymosan in the mouse. Int. J. Tissue React. 13:1991;171-185.
47. Sun X., Wei S., Szabó C., Dusting G. J. Depression of the inotropic action of isoprenaline by nitric oxide synthase induction in rat isolated hearts. Eur. J. Pharmacol. 320:1997;29-35.
48. Cochrane C. G. Mechanism of oxidant injury of cells. Mol. Aspects Med. 12:1991;137-147.
49. Szabó C., Zingarelli B., O'Connor M., Salzman A. L. DNA strand breakage, activation of poly ADP ribosyl synthetase, and cellular energy depletion are involved in the cytotoxicity in macrophages and smooth muscle cells exposed to peroxynitrite. Proc. Natl. Acad. Sci. USA. 93:1996;1753-1758.
50. Szabó C. DNA strand breakage and activation of poly ADP ribosyltransferase: A cytotoxic pathway triggered by peroxynitrite. Free Radic. Biol. Med. 21:1996;855-869.
51. Szabó C., Zingarelli B., Salzman A. L. Role of poly ADP ribosyltransferase activation in the nitric oxide- and peroxynitrite-induced vascular failure. Circ. Res. 78:1996;1051-1063.
52. Szabó C., Saunders C., O'Connor M., Salzman A. L. Peroxynitrite causes energy depletion and increases permeability via activation of poly ADP ribosyl synthetase in pulmonary epithelial cells. Am. J. Mol Cell. Respir. Biol. 16:1997;105-109.
53. Thiemermann C., Bowes J., Mynny F. P., Vane J. R. Inhibition of the activity of poly(ADP ribose) synthase reduces ischaemia-reperfusion injury in the heart and skeletal muscle. Proc. Natl. Acad. Sci. USA. 94:1997;679-683.
54. Thiemermann C., Ruetten H., Wu C. C., Vane J. R. The multiple organ dysfunction syndrome caused by endotoxin in the rat: Attenuation of liver dysfunction by inhibitors of nitric oxide synthase. Br. J. Pharmacol. 116:1995;2845-2851.
55. Zingarelli B., Ischiropoulos H., Salzman A. L., Szabó C. Mercaptoethylguanidine, and inhibitor of nitric oxide synthase, and a scavenger of peroxynitrite, exerts beneficial effects in hemorrhagic shock. FASEB J. 11:1997;A68.
56. Brahn E., Banquerigo M. L., Firestein G. S., Boyle D. L., Salzman A. L., Szabó C. Beneficial effects of mercaptoethylguanidine, an inhibitor of nitric oxide synthase and a scavenger of peroxynitrite, in collagen-induced arthritis: Inhibition of synovitis and suppression of TNF-α, collagenase and stromeolysin. FASEB J. 11:1997;A530.
57. Xia Y., Dawson V. L., Dawson T. M., Snyder S. H., Zweier J. L. Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc. Natl. Acad. Sci. USA. 93:1996;6770-6774.